Biotech Entrepreneur Aldag Inspired By Italy's Genespire
New Chairman of Milan-Based Gene Therapy Firm
Executive Summary
Jörn Aldag, who has over 20 years of leadership experience in the life sciences industry, including CEO of gene therapy pioneer uniQure, tells Scrip that the research carried at the world-class Italian research institute SR-Tiget.
You may also be interested in...
Merck KGaA Rebounds After COVID-19 Lockdowns
The coronavirus pandemic hurt the German group's healthcare division but helped the contract development and manufacturing activities of Merck's life sciences business.
Roche Pharma Chief Picks Out Pearls in Cancer Pipeline
Oncology is an area where the Swiss major has long been a dominant player, and Bill Anderson highlighted programs to Scrip which Roche hopes will help extend that dominance.
Roche To Reinvest Savings Into R&D And Keep Prices Low
The Swiss major's pharma chief Bill Anderson tells Scrip that the goal for the firm over the next decade is to deliver twice as many medicines at a much lower cost to society.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports